-
Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc.
J Clin Invest. 2000 Jul;106(2):207-15
PMID: 10903336
-
Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.
Cell. 2000 Oct 13;103(2):351-61
PMID: 11057907
-
Crystal structure of human protein-tyrosine phosphatase SHP-1.
J Biol Chem. 2003 Feb 21;278(8):6516-20
PMID: 12482860
-
The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.
Rheumatology (Oxford). 2003 May;42 Suppl 2:ii3-10
PMID: 12817089
-
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.
Trends Biochem Sci. 2003 Jun;28(6):284-93
PMID: 12826400
-
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.
Nature. 2003 Aug 14;424(6950):743-8
PMID: 12872135
-
Lps2: a new locus required for responses to lipopolysaccharide, revealed by germline mutagenesis and phenotypic screening.
J Endotoxin Res. 2003;9(4):250-5
PMID: 12935356
-
Activated Ets2 is required for persistent inflammatory responses in the motheaten viable model.
J Immunol. 2004 Jul 15;173(2):1374-9
PMID: 15240733
-
An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.
Blood. 2004 Aug 1;104(3):735-43
PMID: 15069016
-
Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology.
J Hered. 1975 Sep-Oct;66(5):250-8
PMID: 1184950
-
Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins.
J Immunol. 1976 Apr;116(4):936-43
PMID: 56406
-
Motheater: an immunodeficient mouse with markedly less ability to survive that the nude mouse in a germfree environment.
J Immunol. 1976 May;116(5):1496-7
PMID: 1270804
-
"Viable motheaten," a new allele at the motheaten locus. I. Pathology.
Am J Pathol. 1984 Aug;116(2):179-92
PMID: 6380298
-
Pleiotropic effects of deleterious alleles at the "motheaten" locus.
Curr Top Microbiol Immunol. 1988;137:216-22
PMID: 3416633
-
SH2 domains recognize specific phosphopeptide sequences.
Cell. 1993 Mar 12;72(5):767-78
PMID: 7680959
-
Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene.
Cell. 1993 Jul 2;73(7):1445-54
PMID: 8324828
-
Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene.
Nat Genet. 1993 Jun;4(2):124-9
PMID: 8348149
-
Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice.
J Exp Med. 1993 Dec 1;178(6):2157-63
PMID: 8245788
-
Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
Structure. 1994 May 15;2(5):423-38
PMID: 7521735
-
Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1.
Mol Cell Biol. 1995 Dec;15(12):7050-8
PMID: 8524272
-
Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1.
Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1141-5
PMID: 8577729
-
B and T cells are not required for the viable motheaten phenotype.
J Exp Med. 1996 Feb 1;183(2):371-80
PMID: 8627150
-
Role of cytokines in rheumatoid arthritis.
Annu Rev Immunol. 1996;14:397-440
PMID: 8717520
-
Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice.
Am J Pathol. 1997 Nov;151(5):1303-10
PMID: 9358756
-
Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor.
Arthritis Rheum. 1998 Jan;41(1):139-49
PMID: 9433879
-
Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2.
Structure. 1998 Mar 15;6(3):249-54
PMID: 9551546
-
Functional consequences of the SHP-1 defect in motheaten viable mice: role of NF-kappa B.
Cell Immunol. 1998 Apr 10;185(1):49-58
PMID: 9636682
-
PanR1, a dominant negative missense allele of the gene encoding TNF-alpha (Tnf), does not impair lymphoid development.
J Immunol. 2006 Jun 15;176(12):7525-32
PMID: 16751399
-
Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis.
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10961-6
PMID: 16832055
-
Toll-like receptors in systemic autoimmune disease.
Nat Rev Immunol. 2006 Nov;6(11):823-35
PMID: 17063184
-
Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis.
J Exp Med. 2007 Apr 16;204(4):853-63
PMID: 17420270
-
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.
Nat Med. 2007 May;13(5):543-51
PMID: 17479100
-
B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity.
Immunity. 2007 Jul;27(1):35-48
PMID: 17600736
-
Cryopyrin-associated periodic syndromes and autoinflammation.
Clin Exp Dermatol. 2008 Jan;33(1):1-9
PMID: 17927785
-
Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1.
Nat Immunol. 2008 May;9(5):542-50
PMID: 18391954